Lysine methylation is a widespread posttranslational modification (PTM) in eukaryotes whose protein regulatory functions have been illuminated through studies of histone lysine methylation and its key connections to chromatin and epigenetic regulation. Beyond histones, a major gap in knowledge is broadening between the rapidly expanding lysine methylome and the proteins responsible for the addition, removal, and recognition of these PTMs. As several inhibitors of lysine methylation regulators are in preclinical and clinical development for cancer therapy, defining the full target spectrum of these proteins is critical for understanding mechanisms of action for these drugs, to rationalize potential combination therapies, and to identify reliable biomarkers for clinical activity. Here we debut the development of a high‐throughput and unbiased functional proteomics platform that queries the activities of lysine methyltransferases (KMTs) and generates molecular footprints that can be mapped to protein targets. We demonstrate the utility of this platform towards the discovery of novel substrates for KMTs. Full implementation of this platform will provide critical systems level information to enable the construction of lysine methylation signaling networks and will facilitate fundamental understanding of lysine methylation function in human health and disease. Support or Funding Information Van Andel Research Institiute, Van Andel Institute Employee Impact Campaign, and EpiCypher